Krsnaa Diagnostics Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Krsnaa Diagnostics share price target 2026 stands at Rs 750-867 as per analyst consensus — implying 21-39% upside from the current CMP of Rs 622. Investors tracking the Krsnaa Diagnostics share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Krsnaa Diagnostics (KRSNAA) achieves or misses this 12-month target. This article covers every dimension of the Krsnaa Diagnostics share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Krsnaa Diagnostics on Univest.

Table of Contents

Krsnaa Diagnostics Share Price Overview — April 2026

Company	Krsnaa Diagnostics
NSE Symbol	KRSNAA
Sector	Diagnostics / Government PPP / Radiology / Pathology
CMP April 2026	Rs 622
52-Week High	Rs 982
52-Week Low	Rs 497
Market Cap	Rs 1,560 Cr
Trailing P/E	28x
Dividend FY26	Rs 2
Promoter Holding	44.0%
FII Holding	8.4%
12M Analyst Target	Rs 750-867
Upside from CMP	21-39%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Krsnaa Diagnostics price, FII/DII flows and analyst targets on the Univest Screener.

What Is Krsnaa Diagnostics?

Get Free Analyst Research on Krsnaa Diagnostics — Tap Here.

Krsnaa Diagnostics (NSE: KRSNAA) operates India’s largest government-PPP diagnostics network — radiology, pathology, wellness in government hospitals across Tier 2 and 3 cities. 75%+ revenues from assured PPP contracts. FY26 revenue Rs 650+ crore growing 20%+.

Budget 2026-27 Impact on Diagnostics

Budget 2026-27’s Rs 90,000 crore health allocation and Ayushman diagnostic empanelment expansion directly benefit Krsnaa’s PPP contract pipeline.

Krsnaa Diagnostics share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 750	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 750-867	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 497 zone	FY27 miss and extended FII selling

Compare Krsnaa Diagnostics with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Krsnaa Diagnostics share price target 2026

1. India Diagnostics Sector — Structural Growth Tailwind

India’s Diagnostics sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Krsnaa Diagnostics’s market position within this sector creates compounding runway that underpins the Krsnaa Diagnostics share price target 2026 consensus of Rs 750-867. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Krsnaa Diagnostics to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Krsnaa Diagnostics share price target 2026 consensus of Rs 750-867. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Krsnaa Diagnostics holds a structural competitive moat in its Diagnostics segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Krsnaa Diagnostics share price target 2026 of Rs 750-867.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Krsnaa Diagnostics’s borrowing costs and stimulates end-customer demand for Diagnostics products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Krsnaa Diagnostics share price target 2026 of Rs 750-867 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Krsnaa Diagnostics’s Diagnostics business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Krsnaa Diagnostics share price target 2026 bull case.

Download the Univest iOS App or Android App for live Krsnaa Diagnostics alerts and SEBI-registered research.

5 Risks That Could Impact the Krsnaa Diagnostics share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Krsnaa Diagnostics. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Krsnaa Diagnostics share price target 2026 consensus of Rs 750-867.

2. Valuation at 28x Requires Consistent Execution

At 28x trailing P/E, Krsnaa Diagnostics is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Krsnaa Diagnostics share price target 2026. The Rs 497 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in Diagnostics

Domestic and global competitors are investing aggressively in Krsnaa Diagnostics’s Diagnostics market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Krsnaa Diagnostics share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Krsnaa Diagnostics share price target 2026 of Rs 750-867.

5. FII Selling Risk — 8.4% Institutional Holding

With 8.4% FII ownership, Krsnaa Diagnostics is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Krsnaa Diagnostics share price target 2026 analyst consensus of Rs 750-867.

Krsnaa Diagnostics Bull Case vs Bear Case — Krsnaa Diagnostics share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	867	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 750-867	High	FY27 in-line earnings, stable macro
Bear Case	Rs 497 zone	Low	FY27 guidance cut, prolonged FII selling

Krsnaa Diagnostics Share Price Reference Table

NSE Symbol	KRSNAA
CMP	Rs 622
52-Week High	Rs 982
52-Week Low	Rs 497
Market Cap	Rs 1,560 Cr
P/E	28x
Promoter	44.0%
FII	8.4%
Dividend FY26	Rs 2
Short-Term Target	Rs 750
12M Target	Rs 750-867
Upside	21-39%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Krsnaa Diagnostics share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 746	FY27 earnings recovery and Diagnostics sector leadership
YES Securities	Buy	Rs 758	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 715	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Krsnaa Diagnostics.

How to Invest in Krsnaa Diagnostics — 5 Steps

Step 1: Research on the Univest Screener

Search KRSNAA on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Krsnaa Diagnostics share price target 2026.

Step 2: Identify Entry Level

Krsnaa Diagnostics at Rs 622 has key support near Rs 497. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Krsnaa Diagnostics share price target 2026 recovery is Rs 750.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 867 — the bull case for the Krsnaa Diagnostics share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Krsnaa Diagnostics share price target 2026.

Conclusion — Krsnaa Diagnostics share price target 2026

Krsnaa Diagnostics (KRSNAA) at Rs 622 offers 21-39% potential upside to the 12-month Krsnaa Diagnostics share price target 2026 consensus of Rs 750-867. The bull case to 867 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 497 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Krsnaa Diagnostics at current levels presents a monitored entry opportunity. For more Krsnaa Diagnostics share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Krsnaa Diagnostics share price target 2026

Q: What is Krsnaa Diagnostics share price target for 2026?

The 12-month Krsnaa Diagnostics share price target 2026 analyst consensus is Rs 750-867 — implying 21-39% upside from CMP Rs 622. Bull case: 867. Bear case: Rs 497 zone. Track the live Krsnaa Diagnostics share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Krsnaa Diagnostics a good buy at Rs 622?

This article does not constitute investment advice. At Rs 622, Krsnaa Diagnostics offers 21-39% upside to the Krsnaa Diagnostics share price target 2026 consensus of Rs 750-867. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Krsnaa Diagnostics 52-week high and low?

Krsnaa Diagnostics’s 52-week high is Rs 982 and 52-week low is Rs 497. At the current CMP of Rs 622, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Krsnaa Diagnostics share price target 2026 thesis.

Q: What sector is Krsnaa Diagnostics (KRSNAA) in?

Krsnaa Diagnostics operates in the Diagnostics / Government PPP / Radiology / Pathology sector. India’s Diagnostics sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Krsnaa Diagnostics share price target 2026 bull case.

Q: What are the main risks for the Krsnaa Diagnostics share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at 28x requiring consistent execution, competition in Diagnostics, input cost volatility, and FII selling pressure (8.4% holding). Monitor quarterly earnings closely.

Q: What is Krsnaa Diagnostics’s market cap?

Krsnaa Diagnostics has a market cap of Rs 1,560 Cr as of April 2026. At the Krsnaa Diagnostics share price target 2026 of Rs 750-867, the implied market cap would reflect 21-39% appreciation on the current base.

Q: What is Krsnaa Diagnostics dividend for FY26?

Krsnaa Diagnostics’s FY26 dividend is Rs 2. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Krsnaa Diagnostics share price target 2026 capital appreciation potential.

Q: How to buy Krsnaa Diagnostics shares?

Buy Krsnaa Diagnostics (KRSNAA) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 497 support zone, and download the Univest App for SEBI-registered research on the Krsnaa Diagnostics share price target 2026.